Introduction
Diabetes is today a worldwide problem. The global prevalence of diabetes is estimated to increase still further, it is projected that by 2025 there will be 380 million people with type 2 diabetes and 418 million people with impaired glucose tolerance1 and India the situation is going to be more difficult as it has been reported that by 2025 India will be the hub of diabetes. People with diabetes are also at increased risk of developing cardiovascular, peripheral vascular and cerebrovascular disease. Hence this disease is also called as a “silent killer”.2, 3
But a new emerging complication is the impact of the disease on the Bone health. It has been observed that diabetic patients are at a greater risk of fracture due to poor quality of the bones. At the same time, healing is delayed in diabetes, including nonunion. Bone has been known to be required for three classical functions of Organ protection, locomotion, and calcium–phosphorus homeostasis. There is a constant renewing by remodeling which helps in the repair of the microdamage and participates in fracture healing. This remodeling is effected in the diabetic individuals due to hyperglycemia.4 These observations evoked interest to conduct this study because women generally neglect their health and hence it was interesting to analyze the bone health in Indian Diabetic women.
Materials and Methods
The study enrolled 330 individuals i.e 180 Diabetic subjects (group I and III) and control group comprising of 150 healthy subjects (group II & IV). Dividing into four group i.e group I included Pre Menopausal with type II DM (n=80), group II was age matched control (n=75), group III were Post Menopausal with type II DM (n=100) and group IV (n=75) were age matched Post Menopausal control group. No subject was included who had a previous history of stroke, myocardial infarction or any other cardiovascular disease. The study protocol was approved by the Ethics Committee of the Institution and all the subjects included in the study volunteered after proper consent taken. All ethical norms were followed during the study.
Collection of specimen
After 12 hrs of fast, venous blood sample were collected in different bulbs under aseptic conditions. EDTA bulb was used for glycated hemoglobin estimation by resin binding method.5 Plain bulb was used for estimation of serum Calcium, Phosphorous, Magnesium. Glycosylated hemoglobin, TRAP, Osteocalcin, Serum Alkaline Phosphatase, Serum Calcium, Serum Phosphorous were estimated by commercially available kit. While Serum Magnesium,6 Superoxide dismutase (SOD) by Marklund and Marklund,7 malondialdehyde (MDA) by Wilbur K. M et al.8 Acid citrate bulb was used for erythrocyte reduced glutathione(GSH) measurement by method of Beutler et al.9
Results
Table 1 shows that HbA1C is very significantly increased (p<0.0001) in group I & III as they are diabetic subjects with type II Pre and Post menopausal diabetic women respectively.
Table 2 shows, serum MDA parameter of lipid peroxidation and antioxidants like GSH, GPx,G red and SOD.MDA levels have been very significantly increased (p<0.0001) in the group I & III DM subjects than the respective control groups. While the antioxidants show and interesting trend in group I i.e Pre Menopausal women but the antioxidant levels were not significant in group III even when MDA levels were very high. The levels of SOD have been very significantly decreased (p<0.0001) in the Post menopausal diabetic women than the control group while a no significant variation could be observed in the levels of GSH, GPx, G red when compared to the control.
Table 3 indicates the Bone minerals,Osteoblastic and Osteoclastic activity in various groups. It has observed that the Serum Calcium and Serum Magnesium levels were significantly low in the premenopausal diabetic women. The Osteoblastic activity (i.e measured by Sr. Alkaline Phosphatase and Osteocalcin) was significantly low (p<0.0001) while Osteoclastic activity (Sr.TRAP) was found to be significantly increased (p<0.0001) in the Pre Menopausal diabetic group.
Table 1
Table 2
Table 3
Table 4
Discussion
In the present study, we have observed an increased (p<0.0001) level of glycosylated hemoglobin which was used as an index of metabolic control in the study group in both pre and post menopausal diabetic women (Table 1). It is this “glucose toxicity” which leads to cellular dysfunction that become irreversible over a period of time. Hyperglycemia induces increased synthesis of reactive oxygen species via oxidative phosphorylation during anaerobic glycolysis, via the Schiff reaction during glycation, via glucose autoxidation, and via hexosamine metabolism under supraphysiological glucose concentrations. In the present study as per indicated in Table 2 an increased level of MDA was observed in comparison to control (p<0.0001). This is in accordance with previous finding that hyperglycemia induces over production of oxygen free radicals in diabetes.10, 11 In the present study it was observed that in the premenopausal women though had a raised MDA levels (6.75 ± 2.42) indicating oxidative stress but it was getting counter balanced by the increased level of antioxidants i.e GSH, GPx, Gred, SOD while in the post menopausal women the levels of the GSH, GPx, Gred were not increased through an oxidative stress was observed (MDA level 8.03 ± 1. 28). This might be due to the prolonged exposure to hyperglycemia which inactivates the enzymes.11, 12 The levels of SOD was observed to the significantly low (p<0.0001) in group III when compared with group IV indicating “Oxidative stress” which has been observed by other researcher.13 Thus indicating that the combined effect of Oxidative stress and depleted antioxidant defense system causes oxidative injury. The result of the present study indicates that hyperglycemia caused increased production of free radical (Table 4) as a significant positive correlation (p<0.0001) between glycosylated hemoglobin and MDA in pre and post menopausal women. While a significant negative correlation (p<0.0001) observed between the various antioxidants with MDA only in group I while this is through indicating negative correlation but not significant.
The levels of the bone minerals i.e Sr. Calcium showed a significant change ((p<0.001) in pre menopausal women but the Sr. Phosphorous levels were unaltered in all the study subjects. At the same time levels of Sr Magnesium showed a decrease in the premenopausal (p<0.0001) and post menopausal women (p<0.001).
On the other hand hyperglycemia and Oxidative stress both are said to have a crucial role in bone pathophysiology.14 The current study used Sr TRAP as the marker of bone resoption while Sr Osteocalcin and Sr Alkaline phosphatase as bone formation. In our study the level of TRAP was significantly high (p<0.0001) in the post and pre menopausal diabetic women than the respective control at the same time markers of bone formation are indeed decreased similar to other study done.15, 16, 17, 18 But the levels of Sr. Alkaline phosphatase was slightly decreased. This pattern of changes suggests that an extent of imbalance of bone resorption and bone formation does occur in the diabetic individual though there are other factors that govern it. (p<0.0001). When this is clubbed with the decreased magnesium levels it can be understood that magnesium is an important factor of the bone matrix which determine the bone fragility. Hence magnesium depletion can affects all stages of skeletal metabolism adversely, leading to cessation of bone growth, decreased osteoblastic and osteoclastic activity, osteopenia and bone fragility.19, 20
Conclusion
All this indicates that hyperglycemia over a period of time results in Oxidative stress and affects the bone health in the diabetic women. The body mechanism is able to resist this damage by the antioxidants in the pre menopausal age but as menopause sets it the risk of bone fragility is observed to be increased. Hence the risk of fracture is increased. So care should be taken to monitor and maintain the blood sugar levels.